CS
TWST icon

Candriam SCA’s Twist Bioscience TWST Stock Holding History

Candriam SCA’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-71,360
Closed -$2.63M – 734
2023
Q4 		$2.63M Sell
71,360
-36,000
-34% -$832K 0.02% 447
2023
Q3 		$2.18M Sell
107,360
-227,000
-68% -$4.99M 0.02% 439
2023
Q2 		$6.84M Buy
334,360
+25,000
+8% +$375K 0.05% 293
2023
Q1 		$4.29M Buy
309,360
+100,000
+48% +$2.21M 0.03% 401
2022
Q4 		$4.98M Buy
209,360
+106,000
+103% +$3.07M 0.03% 380
2022
Q3 		$3.64M Buy
103,360
+26,519
+35% +$1.13M 0.03% 451
2022
Q2 		$2.69M Hold
76,841
– – 0.02% 438
2022
Q1 		$3.79M Buy
76,841
+4,000
+5% +$222K 0.03% 402
2021
Q4 		$5.64M Hold
72,841
– – 0.04% 339
2021
Q3 		$7.79M Hold
72,841
– – 0.05% 319
2021
Q2 		$9.71M Buy
+72,841
New +$8.47M 0.07% 290

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Candriam SCA's TWST Position: Q1 2024 in Review

Candriam SCA sold out of Twist Bioscience (TWST) in Q1 2024, closing a stake of 71,360 shares — an estimated $2.63M sold.

Candriam SCA first reported a position in TWST in Q2 2021 and held it in 11 quarters. The position peaked at $9.71M in Q2 2021. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

  • Candriam SCA reported no remaining Twist Bioscience position as of Q1 2024 after selling out during the quarter.
  • Candriam SCA sold 71,360 Twist Bioscience shares in Q1 2024, an estimated $2.63M.
  • Candriam SCA first reported a position in Twist Bioscience in Q2 2021 and held it in 11 quarters.
  • Candriam SCA's Twist Bioscience position peaked at $9.71M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.